2022
Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia
Bazazi A, Culbert G, Wegman M, Heimer R, Kamarulzaman A, Altice F. Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia. BMC Infectious Diseases 2022, 22: 837. PMID: 36368939, PMCID: PMC9652918, DOI: 10.1186/s12879-022-07804-6.Peer-Reviewed Original ResearchConceptsOpioid use disorderOpioid agonist therapyInfectious etiologyMost deathsUse disordersSample of menPrison releaseOpen-label trialT-lymphocyte countsPredictors of mortalityNational death recordsCrude mortality rateProportional hazards modelCovariate-adjusted modelsLow CD4Methadone initiationModified intentionAgonist therapySurvival benefitTreat analysisMethodsThis studyHIVHazards modelMortality rateMethadone
2017
Predictors of mortality within prison and after release among persons living with HIV in Indonesia
Culbert GJ, Crawford FW, Murni A, Waluyo A, Bazazi AR, Sahar J, Altice FL. Predictors of mortality within prison and after release among persons living with HIV in Indonesia. Research And Reports In Tropical Medicine 2017, Volume 8: 25-35. PMID: 29238241, PMCID: PMC5724785, DOI: 10.2147/rrtm.s126131.Peer-Reviewed Original ResearchAntiretroviral therapyCrude mortality rateOpportunistic infectionsMortality rateCox proportional hazards regression modelProportional hazards regression modelsAdvanced HIV infectionPredictors of mortalityHazards regression modelsCommon probable causesIndonesian prisonersCause mortalityHIV infectionImmediate family membersOverall mortalityMortality predictorsHIV treatmentKaplan-MeierSurvival overallLonger survivalMedical recordsImmune functionHIVMortalityAddiction treatment